Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study

Lung cancer, chronic obstructive pulmonary disease (COPD), and coronary artery disease (CAD) are expected to cause most deaths by 2050. State-of-the-art computed tomography (CT) allows early detection of lung cancer and simultaneous evaluation of imaging biomarkers for the early stages of COPD, base...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Congying, Rook, Mieneke, Pelgrim, Gert Jan, Sidorenkov, Grigory, Wisselink, Hendrik J., van Bolhuis, Jurjen N., van Ooijen, Peter M. A., Guo, Jiapan, Oudkerk, Matthijs, Groen, Harry, van den Berge, Maarten, van der Harst, Pim, Dijkstra, Hildebrand, Vonder, Marleen, Heuvelmans, Marjolein A., Dorrius, Monique D., De Deyn, Peter Paul, de Bock, Geertruida H., Dotinga, Aafje, Vliegenthart, Rozemarijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
New Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058676/
https://www.ncbi.nlm.nih.gov/pubmed/31016436
http://dx.doi.org/10.1007/s10654-019-00519-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058676/
https://www.ncbi.nlm.nih.gov/pubmed/31016436
http://dx.doi.org/10.1007/s10654-019-00519-0

Ejemplares similares